Diabetes Management Platform, HealthPlix Expands its Services to Delhi, Hyderabad and Pune

Monday, June 20, 2016 Indian Health News
Email Print This Page Comment bookmark
Font : A-A+

BANGALORE, June 20, 2016 /PRNewswire/ --

- The Company Currently Present in Bangalore,

Expands its Operations to Delhi, Hyderabad and Pune 

- At Present, HealthPlix has Over 1

,000 Patients and 33 Doctors on Their Platform in Bangalore  

- Is Looking to Add 20,000 Patients and 450 Doctors on Their App and Platform by the End of 2016  

After successfully transforming the lives of more than 1,000 diabetes patients in Bangalore, HealthPlix, a one-stop solution for diabetes management, has launched its operations in Delhi, Hyderabad and Pune. The company aims to transform diabetes care by improving the doctor-patient interaction for close monitoring of the patient's diabetic condition.

India is witnessing a burgeoning problem of diabetes mismanagement which is the source of several serious health conditions. To manage such chronic diseases, along with constant physical attention, these patients need continuous medical guidance and a change in their day-to-day lifestyle. HealthPlix is addressing the diabetes mismanagement problem by helping doctors personalize on-going medical care for chronic diabetes patients. Further, HealthPlix helps doctors achieve treatment personalization at scale.

Using HealthPlix, a patient can get his or her doctor to review the important vitals such as blood sugar, blood pressure, insulin intake, physical activity on a day-to-day basis. The ease with which the patients are able to get their doctor to review and offer advice on their diabetic condition is helping patients reach their treatment goals much faster and thus, dramatically lowering the risks of serious health complications.

HealthPlix is making the interaction between the patient and their doctor for chronic diabetes care seamless, quick and more efficient than the conventional approach being followed today. When doctors use HealthPlix app and platform to treat their diabetes patients, they are augmenting their current clinical setup to make it well-suited for the needs of management of chronic diabetes.

Commenting on the development, Raghuraj Sunder Raju, Founder and CEO, HealthPlix, said, "India is the diabetes capital of the world with over 70 million people affected by the disease with an estimated another 80 million in the pre-diabetes stage. With HealthPlix, we aim to bring in a paradigm change in the chronic disease management space. Currently 33 leading diabetologists and endocrinologists in Bangalore have reposed their faith in our app and platform for their patients. We would like to extend the benefits of our product to more patients by bringing in an additional 400 doctors on our platform by the end of this year. Bangalore has been a good kick-start for the company; we have received an overwhelming response from both doctors and patients. Looking forward to receiving the same in Pune, Hyderabad and Delhi."

About HealthPlix: 

HealthPlix, a healthcare tech company, offers one-stop technology solution for diabetes management. The company's singular purpose is to help improve the treatment outcomes in chronic diabetes care. Using a sophisticated yet user friendly mobile health app for the patients backed by a robust platform, it organizes chronic diabetes care for the patients. Doctors use HealthPlix platform and app to provide on-going chronic diabetes care for their patients with the purpose of identifying the best treatment options for an individual patient. The HealthPlix app is integrated with a custom designed Electronic Health Record software for chronic care. This offers immense flexibility for the doctors to provide care either through a mobile app or through a desktop based software.

Link to download the app: 



For more information, please visit: http://www.healthplix.com/

Media Contact: Raghuraj Sunder Raju raghuraj@healthplix.com +91-9901905793 Founder and CEO HealthPlix Technologies Private Limited

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store